Plasma oxytocin in response to pharmaco-challenge to D-fenfluramine and placebo in healthy men. (Q44473310)

3 December 2017

title

Plasma oxytocin in response to pharmaco-challenge to D-fenfluramine and placebo in healthy men. (English)

1 reference

3 December 2017

1 reference

1 reference

Royce Lee

1

1 reference

3 December 2017

Francisca Garcia

2

1 reference

3 December 2017

Louis D van de Kar

3

1 reference

3 December 2017

Richard D Hauger

4

1 reference

3 December 2017

Emil F Coccaro

5

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

118

1 reference

3 December 2017

issue

2

1 reference

3 December 2017

page(s)

129-136

1 reference

Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(03)50070-2

7 January 2021

Effect of 5-HT1C and 5-HT2 receptor stimulation on excessive grooming, penile erection and plasma oxytocin concentrations

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(03)50070-2

7 January 2021

Role of the hypothalamic paraventricular nucleus in 5-HT1A, 5-HT2A and 5-HT2C receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(03)50070-2

7 January 2021

Paraventricular nucleus controls 5-HT2C receptor-mediated corticosterone and prolactin but not oxytocin and penile erection responses

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(03)50070-2

7 January 2021

Gender-dependent dissociation between oxytocin but not ACTH, cortisol or TSH responses to m-chlorophenylpiperazine in healthy subjects

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(03)50070-2

7 January 2021

Oxytocin response to challenging stimuli in elderly men.

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(03)50070-2

7 January 2021

Neuroendocrine and hypothermic effects of 5-HT1A receptor stimulation with ipsapirone in healthy men: a placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(03)50070-2

7 January 2021

Physiological responses to d-fenfluramine and ipsapirone challenge correlate with indices of aggression in males with personality disorder

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(03)50070-2

7 January 2021

5-HT2a/2c receptor blockade by amesergide fully attenuates prolactin response to d-fenfluramine challenge in physically healthy human subjects

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(03)50070-2

7 January 2021

5-HT3 receptor antagonism by ondansetron does not attenuate prolactin response to d-fenfluramine challenge in healthy human subjects

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(03)50070-2

7 January 2021

Hormonal responses to d- and d,l-fenfluramine in healthy human subjects

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(03)50070-2

7 January 2021

Pharmacological characterization of serotonin receptors involved in the control of prolactin secretion

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(03)50070-2

7 January 2021

Daily patterns of secretion of neurohypophysial hormones in man: effect of age

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(03)50070-2

7 January 2021

D-Fenfluramine induces serotonin-mediated Fos expression in corticotropin-releasing factor and oxytocin neurons of the hypothalamus, and serotonin-independent Fos expression in enkephalin and neurotensin neurons of the amygdala

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(03)50070-2

7 January 2021

Enkephalin inhibition of angiotensin-stimulated release of oxytocin and vasopressin

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(03)50070-2

7 January 2021

Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(03)50070-2

7 January 2021

Attenuation of hormone responses to the 5-HT1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(03)50070-2

7 January 2021

D-fenfluramine activates rat oxytocinergic and vasopressinergic neurons through different mechanisms

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(03)50070-2

7 January 2021

Simultaneous microdialysis in blood and brain: oxytocin and vasopressin release in response to central and peripheral osmotic stimulation and suckling in the rat

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(03)50070-2

7 January 2021

Low doses of ipsapirone increase growth hormone but not oxytocin secretion in normal male and female subjects

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(03)50070-2

7 January 2021

d-Fenfluramine/prolactin response throughout the menstrual cycle: evidence for an oestrogen-induced alteration

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(03)50070-2

7 January 2021

Effect of pindolol on the prolactin response tod-denfluramine

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(03)50070-2

7 January 2021

The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(03)50070-2

7 January 2021

5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells

1 reference

https://api.crossref.org/works/10.1016/S0165-1781(03)50070-2

7 January 2021

10.1016/S0165-1781(03)00070-2

Identifiers

DOI

1 reference

3 December 2017

1 reference